Previous 10 | Next 10 |
2023-11-09 07:30:35 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s time to start the day with a breakdown of the biggest pre-market stock movers worth keeping tabs on for Thursday! Earnings reports continue to be a major catalyst for stocks thi...
CGG ADR (CGGYY) is expected to report for quarter end 2023-09-30 ATI Physical Therapy Inc. Class A (ATIP) is expected to report $-4.08 for Q3 2023 Riot Platforms Inc. (RIOT) is expected to report $-0.29 for Q3 2023 Bain Capital Specialty Finance Inc. (BCSF) is expected to report $0.57...
Allakos Inc. (ALLK) is expected to report $-0.46 for Q3 2023
2023-09-27 14:47:10 ET More on Allakos Scratching The Surface: Allakos' Novel Take On Urticaria Seeking Alpha’s Quant Rating on Allakos Historical earnings data for Allakos Financial information for Allakos For further details see: Allokos ...
2023-09-27 12:10:16 ET Shares of clinical-stage biotech company Allakos (NASDAQ: ALLK) were up more than 15% as of 11:40 a.m. on Wednesday. The stock got a boost when an analyst initiated coverage. Despite the rise, Allakos' stock is still down more than 70% so far this year. Al...
2023-09-27 09:59:57 ET More on Health Care Select Sector SPDR Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare (XLV) BofA Securities: Which small cap non-earner stocks to avoid Health Care Select Sector SPDR ETF declares quarterly distribution of $0.53...
2023-09-27 08:30:53 ET MillerKnoll ( MLKN ) +17% rides 18% higher, sees improving organic orders during FQ1. Gaucho Group Holdings ( VINO ) +15% . Ginkgo Bioworks Holdings ( DNA ) +16% Announces Multi-Target RNA Discovery Collaboration w...
2023-09-18 02:07:15 ET Summary Allakos displays fiscal discipline with YoY reductions in R&D and G&A, suggesting resource reallocation to pivotal assets like lirentelimab. Lirentelimab's Phase 2a data is promising, particularly for omalizumab-refractory patients, but late-...
2023-09-11 17:20:07 ET Gainers: Matrix Service ( MTRX ) +10% . Adeia ( ADEA ) +7% . Allakos ( ALLK ) +5% . Nurix Therapeutics ( NRIX ) +5% . ADMA Biologics ( ADMA ) +4% . Losers: ACELYRIN ( SLRN ) ...
SAN CARLOS, Calif., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Allakos Inc. (Nasdaq: ALLK), a clinical-stage biotechnology company developing therapeutics which target immunomodulatory receptors present on immune effector cells involved in allergy, inflammatory and proliferative diseases, today announced ...
News, Short Squeeze, Breakout and More Instantly...
Allakos Inc. Company Name:
ALLK Stock Symbol:
NASDAQ Market:
SAN CARLOS, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing antibodies for the treatment of allergic, inflammatory and proliferative diseases, today provided a business update and reported financial results for...
SAN CARLOS, Calif., March 14, 2024 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing antibodies for the treatment of allergic, inflammatory and proliferative diseases, today provided a business update and reported financial results f...